AdaptHealth Stock Forecast, Price & News

-0.03 (-0.12 %)
(As of 09/20/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume716,737 shs
Average Volume1.16 million shs
Market Capitalization$3.14 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive AHCO News and Ratings via Email

Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter.

AdaptHealth logo

About AdaptHealth

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.


AdaptHealth Update
AdaptHealth Update
September 19, 2021 |
See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

2.47 out of 5 stars

Medical Sector

126th out of 1,352 stocks

Home Health Care Services Industry

4th out of 10 stocks

Analyst Opinion: 3.4Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

AdaptHealth (NASDAQ:AHCO) Frequently Asked Questions

Is AdaptHealth a buy right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last year. There are currently 1 sell rating and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AdaptHealth stock.
View analyst ratings for AdaptHealth
or view top-rated stocks.

What stocks does MarketBeat like better than AdaptHealth?

Wall Street analysts have given AdaptHealth a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AdaptHealth wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting AdaptHealth?

AdaptHealth saw a increase in short interest during the month of August. As of August 13th, there was short interest totaling 5,470,000 shares, an increase of 18.1% from the July 29th total of 4,630,000 shares. Based on an average daily trading volume, of 962,200 shares, the days-to-cover ratio is currently 5.7 days. Currently, 5.9% of the company's shares are sold short.
View AdaptHealth's Short Interest

When is AdaptHealth's next earnings date?

AdaptHealth is scheduled to release its next quarterly earnings announcement on Wednesday, November 3rd 2021.
View our earnings forecast for AdaptHealth

How were AdaptHealth's earnings last quarter?

AdaptHealth Corp. (NASDAQ:AHCO) announced its quarterly earnings results on Wednesday, August, 4th. The company reported $0.12 EPS for the quarter, missing the Zacks' consensus estimate of $0.29 by $0.17. The business had revenue of $617 million for the quarter, compared to analysts' expectations of $574.03 million. AdaptHealth had a net margin of 2.40% and a trailing twelve-month return on equity of 8.18%. The company's revenue was up 165.8% compared to the same quarter last year.
View AdaptHealth's earnings history

How has AdaptHealth's stock price been impacted by Coronavirus (COVID-19)?

AdaptHealth's stock was trading at $15.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AHCO shares have increased by 51.8% and is now trading at $24.01.
View which stocks have been most impacted by COVID-19

What guidance has AdaptHealth issued on next quarter's earnings?

AdaptHealth updated its FY 2021 earnings guidance on Thursday, September, 2nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.38 billion-$2.48 billion, compared to the consensus revenue estimate of $2.30 billion.

What price target have analysts set for AHCO?

10 brokerages have issued 1 year target prices for AdaptHealth's shares. Their forecasts range from $36.00 to $50.00. On average, they expect AdaptHealth's stock price to reach $45.17 in the next twelve months. This suggests a possible upside of 88.1% from the stock's current price.
View analysts' price targets for AdaptHealth
or view top-rated stocks among Wall Street analysts.

Who are AdaptHealth's key executives?

AdaptHealth's management team includes the following people:

Who are some of AdaptHealth's key competitors?

What other stocks do shareholders of AdaptHealth own?

What is AdaptHealth's stock symbol?

AdaptHealth trades on the NASDAQ under the ticker symbol "AHCO."

Who are AdaptHealth's major shareholders?

AdaptHealth's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (5.33%), BlackRock Inc. (4.32%), Silvercrest Asset Management Group LLC (1.97%), Geode Capital Management LLC (1.24%), State Street Corp (1.18%) and Morgan Stanley (0.73%). Company insiders that own AdaptHealth stock include Alan G Quasha, Assured Investment Management, Dale B Wolf, Ronald T Mcdaniel, Shaw Rietkerk and Stephen P Griggs.
View institutional ownership trends for AdaptHealth

Which major investors are selling AdaptHealth stock?

AHCO stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Principal Financial Group Inc., Vanguard Group Inc., JPMorgan Chase & Co., FMR LLC, Royal Bank of Canada, Renaissance Technologies LLC, and Maven Securities LTD. Company insiders that have sold AdaptHealth company stock in the last year include Assured Investment Management, Ronald T Mcdaniel, and Shaw Rietkerk.
View insider buying and selling activity for AdaptHealth
or view top insider-selling stocks.

Which major investors are buying AdaptHealth stock?

AHCO stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, Maverick Capital Ltd., Armistice Capital LLC, Kennedy Capital Management Inc., BlackRock Inc., MESIROW FINANCIAL INVESTMENT MANAGEMENT Equity & Fixed Income, and Silvercrest Asset Management Group LLC. Company insiders that have bought AdaptHealth stock in the last two years include Alan G Quasha, Dale B Wolf, and Stephen P Griggs.
View insider buying and selling activity for AdaptHealth
or or view top insider-buying stocks.

How do I buy shares of AdaptHealth?

Shares of AHCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AdaptHealth's stock price today?

One share of AHCO stock can currently be purchased for approximately $24.01.

How much money does AdaptHealth make?

AdaptHealth has a market capitalization of $3.14 billion and generates $1.06 billion in revenue each year. The company earns $-64,480,000.00 in net income (profit) each year or $0.43 on an earnings per share basis.

How many employees does AdaptHealth have?

AdaptHealth employs 4,700 workers across the globe.

What is AdaptHealth's official website?

The official website for AdaptHealth is

Where are AdaptHealth's headquarters?

How can I contact AdaptHealth?

AdaptHealth's mailing address is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. The company can be reached via phone at (610) 630-6357 or via email at [email protected].

This page was last updated on 9/20/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.